Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
about
Production and clinical development of nanoparticles for gene deliveryBench-to-bedside translation of magnetic nanoparticlesLipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectivesNANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Pigmy MicroRNA: surveillance cops in Therapies kingdomDrug delivery systems, CNS protection, and the blood brain barrierMechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides.Cationic lipid nanodisks as an siRNA delivery vehicleHigh-density lipoproteins for the systemic delivery of short interfering RNA.Toward Understanding Non-coding RNA Roles in Intracranial Aneurysms and Subarachnoid HemorrhageMultifunctional core/shell nanoparticles cross-linked polyetherimide-folic acid as efficient Notch-1 siRNA carrier for targeted killing of breast cancerDesign and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA deliveryEpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex.Cycloamylose-nanogel drug delivery system-mediated intratumor silencing of the vascular endothelial growth factor regulates neovascularization in tumor microenvironmentModified-chitosan/siRNA nanoparticles downregulate cellular CDX2 expression and cross the gastric mucus barrier.Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapyNanoporous silica-based protocells at multiple scales for designs of life and nanomedicineReversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrierCluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.Phage display and targeting peptides: surface functionalization of nanocarriers for delivery of small non-coding RNAs.Evaluation of dendrimer type bio-reducible polymer as a siRNA delivery carrier for cancer therapyLigand-targeted theranostic nanomedicines against cancerA glucose carbonate apatite complex exhibits in vitro and in vivo anti-tumour effectsMelittin derived peptides for nanoparticle based siRNA transfection.Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.Cytotoxicity evaluation of carbon-encapsulated iron nanoparticles in melanoma cells and dermal fibroblasts.Recent advances in nanobiotechnology and high-throughput molecular techniques for systems biomedicine.Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.FGFR3 silencing by siRNA inhibits invasion of A549 cellsTherapeutic nucleic acids: current clinical status.Delivery strategies and potential targets for siRNA in major cancer typesS100A11 is a migration-related protein in laryngeal squamous cell carcinoma.Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles.Targeting cancer cell-specific RNA interference by siRNA delivery using a complex carrier of affibody-displaying bio-nanocapsules and liposomes.Molecular Mechanisms and Biological Functions of siRNA.Advances in Lipid Nanoparticles for siRNA Delivery.Molecular Crosstalking among Noncoding RNAs: A New Network Layer of Genome Regulation in Cancer.Selective targeting of point-mutated KRAS through artificial microRNAs.Multifunctionalization of graphene and graphene oxide for controlled release and targeted delivery of anticancer drugs.Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
P2860
Q26752803-599E9895-EA2F-4158-B21C-6BCBBF67C6EBQ26850547-CA6EF8DB-34FA-476F-A8BC-394B30FDECBBQ26859021-6CFC8CB8-F06F-4964-A5D7-236274213B3BQ28078448-5796B945-A317-4618-927F-06E4FD92423FQ28818470-B202CFB3-8353-44B7-A1BC-59BF1819ABEBQ30432845-4CAF0EF9-D7F4-438F-B9ED-D4261BB98815Q33581506-C5B5AAA5-9281-4C05-9457-5C9C8F3B0A45Q33745473-DA1351C9-BC03-4358-B8B6-D1B26BE0B7A4Q33786171-7112D79A-CE63-4DB8-ADF8-7A850AD0E34FQ33917323-67B8C940-8DAA-4AC9-B7E6-223BF109B7D7Q34519604-0DF212DA-F2F9-42B3-B211-D58E843A2FB9Q34782034-E7930331-F0E6-4FCB-AEC4-7D3D76C35C87Q35018628-4373308A-016B-440A-BF35-788140FD5646Q35052033-2C102146-56D7-428E-A197-B7A0B5F614DAQ35187370-5132F248-7A15-431C-A3ED-F46BE9D99150Q35284618-0C1AD0D7-2E45-412F-AA76-AE70C9D00615Q35334027-4F539D60-2F4C-4CF3-A7EE-9457D5078494Q35546832-95E8E3C0-E663-40B6-A0F8-9553F24EDB2CQ35587385-A9A5F8F3-5E86-4DB1-AF41-559F477C7C7BQ35647485-519E5C9E-AE37-4391-8680-02148FBDA2DCQ35691030-A1FDA7C9-64FB-43FE-8BA5-116A836A69FEQ35895637-B7D21B12-EA0E-467D-B2D0-96DEED54C130Q36288499-1A041F36-D7CD-4578-8C9B-868F8B5D744CQ36626455-B39C2062-5C94-4391-82E2-53B7E18FC848Q36919338-19746A80-3CD0-4FE6-8410-BA3604EA4A27Q37115126-56BBDBD3-1FE6-41DF-BB05-6627D00B61D0Q37462618-92E9FCEB-120D-40B3-B6EE-6BDA1130A6C4Q37500100-5BAA94E5-045A-4F5F-A4B4-E65939F43850Q37582147-AA98A14A-D89A-4D2C-A986-E8269335879AQ38816703-977B529E-0679-4ACC-BB90-EEAB2F2B9CEBQ38853191-7CC71B8E-B88B-4CFE-827D-E4975B59ADE2Q39094418-D8636D5C-9789-4C8D-81DD-E2256B743C34Q39113994-53BCC604-9F64-4B34-A7DD-1B1D7D04B5F4Q39135156-26DB8A5E-6772-4FA8-B9C3-D6AD53E5BA5EQ40077184-B576E7FC-6EF9-4049-9761-4EDBD123DD39Q41786279-37EFF129-D7CD-4A5B-89C6-A7BEF3495E80Q43878782-88A8FD85-42AD-469A-BFF8-E6B9BF02E2ADQ45058705-4E66BDCC-779E-47CF-9B3E-4C55CDD066F8Q47745052-AC7D0CF4-000E-4F0B-9A66-785A98EACE59Q48972059-B59DB571-A902-4EBE-BE72-D4D639804CC7
P2860
Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
@en
type
label
Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
@en
prefLabel
Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
@en
P2093
P2860
P921
P356
P1476
Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
@en
P2093
Alberto Gulino
Enzo Di Fabrizio
Ermanno Miele
Gian Paolo Spinelli
Silverio Tomao
P2860
P304
P356
10.2147/IJN.S23696
P407
P577
2012-07-20T00:00:00Z